@article{b85e64e327704ee3a479a267209442d6,
title = "Medication Nonadherence: A Challenging Conundrum for Clinical Trials, Patients, and Clinicians",
keywords = "adherence, clinical trials, health outcomes",
author = "Usman Baber and Blaha, {Michael J.} and Roxana Mehran",
note = "Funding Information: Dr Baber has received honoraria from AstraZeneca and Amgen. Dr Blaha has received grants from the National Institutes of Health, U.S. Food and Drug Administration, American Heart Association, Aetna Foundation, Amgen Foundation, and Novo Nordisk; and has received personal fees from Sanofi, Regeneron, Novartis, Bayer, Akcea, 89Bio, Kaleido, Inozyme, Kowa, Roche, and VoxelCloud outside the submitted work. Dr Mehran has received grants from Abbott Laboratories, AstraZeneca, Bayer, Beth Israel Deaconess, Bristol Myers Squibb, CSL Behring, Daiichi-Sankyo, Medtronic, Novartis Pharmaceuticals, and OrbusNeich; has received personal fees from Abbott Laboratories, Boston Scientific, Medscape/WebMD, Siemens Medical Solutions, PLx Opco dba PLx Pharma, Roivant Sciences, Sanofi, Medtelligence (Janssen Scientific Affairs), and Janssen Scientific Affairs; has received other compensation from Abbott Laboratories, Abiomed, Bristol Myers Squibb, Claret Medical, Elixir Medical, The Medicines Company, Spectranetics/Philips/Volcano, and Watermark Research Partners; and has received nonfinancial support and other compensation from Regeneron Pharmaceuticals and Idorsia Pharmaceuticals.",
year = "2022",
month = aug,
day = "23",
doi = "10.1016/j.jacc.2022.06.010",
language = "English (US)",
volume = "80",
pages = "779--782",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier Inc.",
number = "8",
}